Fibrosis avanzada asociada a esteatohepatitis no alcohólica (NASH) en España: resultados de un estudio Delphi

Aller, Rocío; Calleja, José Luis; Crespo, Javier; Romero Gómez, Manuel; Turnes, Juan; Benmarzouk Hidalgo, Omar J; Subirán, Rafael; Gil, Alicia.
Gastroenterol. hepatol. (Ed. impr.) ; 47(4): 337-346, Abr. 2024. mapas, graf, tab
Artículo en Español | IBECS (España) | ID: ibc-231800

Documentos relacionados

  1. Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: results of a Delphi study.
  2. The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary Care.
  3. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study.
  4. Association between klotho and non-alcoholic fatty liver disease and liver fibrosis based on the NHANES 2007-2016.
  5. Burden of disease due to liver cirrhosis in Mexico.
  6. Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease.
  7. Patients with NAFLD exhibit more advanced fibrosis in liver biopsy than patients with other chronic liver diseases.
  8. Procedural-Related Bleeding in Hospitalized Patients With Liver Disease (PROC-BLeeD): An International, Prospective, Multicenter Observational Study.
  9. [Advances in the diagnosis, treatment, and prognosis of acute decompensatory cirrhosis].
  10. Identifying High-Risk Patients With Nonalcoholic Fatty Liver Disease: An Opportunity for Intervention Within the Primary Care Setting.